Prognostic value of pretreatment PET/CT lean body mass-corrected parameters in patients with hepatocellular carcinoma.

Objective: This study was designed to investigate whether pretreatment fluorine-18-fluorodeoxyglucose (F-FDG) PET/computed tomography (CT) lean body mass-corrected parameters could predict the overall survival (OS) better than the established predictors in patients with hepatocellular carcinoma (HCC).

Patients And Methods: We retrospectively analyzed 61 patients with HCC with pretreatment F-FDG-PET/CT. Besides obtaining clinical factors, we measured both lean body mass-corrected and body weight-corrected PET/CT parameters, including metabolic tumor volume, maximal standardized uptake value of the tumor, total lesion glycolysis, tumor-to-normal liver uptake ratio, and so on.

Preliminary clinical investigation of 99mTc-methoxyisobutylisonitrile washout rate in hypertrophic cardiomyopathy.

Objective: The aim of this study was to investigate the changes in early and late washout rates of 99mTc-methoxyisobutylisonitrile (MIBI) in hypertrophic cardiomyopathy (HCM), and to analyze the relationships between early and late washout rates and the hypertrophic thickness of left ventricular (LV) wall.

Methods: The patients who were clinically diagnosed as positive for HCM underwent 99mTc-MIBI static planar and gated single-photon emission computed tomography (SPECT) imaging. Early (90 min after the intravenous injection) and late (4 h after the intravenous injection) washout rates of 99mTc-MIBI between HCM group and normal control group were compared.